FA
DMTK

Friess Associates’s DermTech, Inc. Common Stock DMTK Stock Holding History

Friess Associates’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-70,433
Closed -$3.58M – 118
2021
Q1 		$3.58M Buy
+70,433
New +$3.68M 1.39% 26
2020
Q4 		– Sell
-234,509
Closed -$2.8M – 136
2020
Q3 		$2.8M Buy
234,509
+39,673
+20% +$460K 0.24% 70
2020
Q2 		$2.58M Buy
+194,836
New +$2.54M 0.24% 72

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Friess Associates's DMTK Position: Q2 2021 in Review

Friess Associates sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 70,433 shares — an estimated $3.58M sold.

Friess Associates first reported a position in DMTK in Q2 2020 and held it in 3 quarters. The position peaked at $3.58M in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Friess Associates reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Friess Associates sold 70,433 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $3.58M.
  • Friess Associates first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Friess Associates's DermTech, Inc. Common Stock position peaked at $3.58M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Friess Associates's 13F filing for Q2 2021, filed 11 Aug 2021.